NSE: SUMICHEM · 27 October 2026
- Sumitomo Chemical India Ltd. (SUMICHEM) declined by 4.16% today, closing at ₹339.55 after opening at ₹347.00. The stock traded within a narrow intraday range, hitting a high of ₹347.00 and slipping to a intraday low of ₹334.10, which matches its 52-week low of ₹334.05.
- Sumitomo Chemical India Ltd. submitted its standalone and consolidated financial results for the quarter and half-year ended 30th September 2026. The company reported operational revenue of ₹907 crore for Q2FY27, marking a 2% year-on-year decrease, driven by soft export demand and the absorption of higher-cost inventory. Gross profit margin contracted to 40.7% and EBITDA margin declined to 20.5% amid a challenging operating environment influenced by a seasonal rainfall deficit.
- Trading volume was 6.60 times the 20-day average daily volume.
Why is Sumitomo Chemical India share price falling on 27 October 2026?
Sumitomo Chemical India Ltd. (SUMICHEM) declined by 4.16% today, closing at ₹339.55 after opening at ₹347.00. The stock traded within a narrow intraday range, hitting a high of ₹347.00 and slipping to a intraday low of ₹334.10, which matches its 52-week low of ₹334.05.
The broader market showed resilience, with the Nifty edging down a negligible 0.02% while the Nifty Metal sector benchmark gained 0.39%. SUMICHEM's underperformance stands out against the backdrop of its broader sectoral trend, extending a sharp correction that includes a 5-day return loss of 13.46% and a 20-day drop of 23.93%, reflecting sustained downward pressure on the stock.
Company fundamentals remain tied to its recent financial disclosures for the quarter ended 30th September 2026, which revealed a 2% year-on-year revenue decline to ₹907 crore and a contraction in EBITDA and PAT margins due to higher-cost inventory absorption and challenging industry headwinds from a rainfall deficit. While these operational updates provide important fundamental context regarding margin pressures and subdued export demand, the sharp downward price movement today appears consistent with broader selling continuation rather than a single new catalyst.
21.62 lakh shares traded by 27 October 2026 · 02:55 PM IST. This compares with a 20-day average daily volume of 3.27 lakh shares (6.60 times). The five-day average daily volume was 3.09 lakh shares. Separately, the NSE report for 26 October 2026 showed 1.74 lakh shares delivered, representing 48.59% of that day’s traded volume. The same report recorded 14,217 trades.
The stock's 4.16% drop extends a prolonged correction, aligning with recent negative multi-week returns and disappointing quarterly margin performance rather than a discrete single-day catalyst.
Latest Company Developments
Sumitomo Chemical India Ltd. submitted its standalone and consolidated financial results for the quarter and half-year ended 30th September 2026. The company reported operational revenue of ₹907 crore for Q2FY27, marking a 2% year-on-year decrease, driven by soft export demand and the absorption of higher-cost inventory. Gross profit margin contracted to 40.7% and EBITDA margin declined to 20.5% amid a challenging operating environment influenced by a seasonal rainfall deficit.
Provides a comprehensive view of the company's financial health, illustrating near-term margin compressions and demand pressures across key product segments.
The company released its investor presentation detailing performance highlights for the quarter and half-year ended 30th September 2026. Management noted that domestic revenue grew 2% to ₹774 crore, while exports dropped 23% to ₹127 crore due to near-term external pressures. The presentation also highlighted the launch of new products such as Topgrain biostimulant and Helibex during the quarter.
Outlines strategic portfolio developments and regional divergence between resilient domestic offtake and pressured export markets.
Sumitomo Chemical India announced key board changes effective 1st September 2026, including the appointment of Dr. Suresh Ramachandran as Managing Director, succeeding Chetan Shantilal Shah who transitioned to a Non-Executive Non-Independent Director role. Several independent director tenures were also updated or renewed during the company's annual cycle.
Reflects structured leadership succession at the top management level to guide the company's medium-term growth objectives.
Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the quarter and half-year ended 30th September, 2026.
Integrated Filing (Financial) for the quarter and half-year ended 30th September, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 7.68% on 30 September 2026. This compares with 7.27% on 30 June 2026, a change of +0.41 percentage points.
The filing reported 33 MF/UTI holders.
What to Watch Next
- Execution of new product launches including Topgrain and Helibex in upcoming quarters
- Recovery trends in export markets following recent contractions
- Management guidance regarding inventory cost normalization and margin recovery
- Subsequent delivery percentages and volume trends relative to the 20-day average
Other Dated Coverage
More Sumitomo Chemical India news and dated analysis →
Frequently Asked Questions
What is the latest Sumitomo Chemical India company news?
Sumitomo Chemical India Ltd. submitted its standalone and consolidated financial results for the quarter and half-year ended 30th September 2026. The company reported operational revenue of ₹907 crore for Q2FY27, marking a 2% year-on-year decrease, driven by soft export demand and the absorption of higher-cost inventory. Gross profit margin contracted to 40.7% and EBITDA margin declined to 20.5% amid a challenging operating environment influenced by a seasonal rainfall deficit.
How strong was Sumitomo Chemical India’s trading volume?
21.62 lakh shares traded, 6.60 times the 20-day average daily volume. The price and volume data are dated 27 October 2026 · 02:55 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.